These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37224459)

  • 41. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
    Zhang M; Truscott J; Davie J
    Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens.
    Alderman MA; Thomas DG; Roh MH
    Diagn Cytopathol; 2013 Nov; 41(11):955-9. PubMed ID: 23584957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OLIG2 is a marker of the fusion protein-driven neurodevelopmental transcriptional signature in alveolar rhabdomyosarcoma.
    Raghavan SS; Mooney KL; Folpe AL; Charville GW
    Hum Pathol; 2019 Sep; 91():77-85. PubMed ID: 31299267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
    Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
    Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pleomorphic Rhabdomyosarcoma: A Systematic Review with Outcome Analysis and Report of a Rare Abdominal Wall Lesion.
    Deb PQ; Chokshi RJ; Li S; Suster DI
    Int J Surg Pathol; 2023 Aug; 31(5):548-556. PubMed ID: 35707991
    [No Abstract]   [Full Text] [Related]  

  • 47. PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms.
    Charville GW; Varma S; Forgó E; Dumont SN; Zambrano E; Trent JC; Lazar AJ; van de Rijn M
    Am J Surg Pathol; 2016 Oct; 40(10):1305-15. PubMed ID: 27526298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ZBTB16: A new biomarker for primitive neuroectodermal tumor element / Ewing sarcoma.
    Xiao GQ; Sherrod AE; Hurth KM
    Pathol Res Pract; 2019 Oct; 215(10):152536. PubMed ID: 31326195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases.
    Tomassen T; Kester LA; Tops BB; Driehuis E; van Noesel MM; van Ewijk R; van Gorp JM; Hulsker CC; Terwisscha-van Scheltinga SEJ; Merks HHM; Flucke U; Hiemcke-Jiwa LS
    Ann Diagn Pathol; 2021 Jun; 52():151735. PubMed ID: 33770660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
    Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
    Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic study of ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV.
    Boué DR; Parham DM; Webber B; Crist WM; Qualman SJ
    Pediatr Dev Pathol; 2000; 3(3):290-300. PubMed ID: 10742419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
    Geller JI; Pressey JG; Smith MA; Kudgus RA; Cajaiba M; Reid JM; Hall D; Barkauskas DA; Voss SD; Cho SY; Berg SL; Dome JS; Fox E; Weigel BJ
    Cancer; 2020 Dec; 126(24):5303-5310. PubMed ID: 32914879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
    Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
    Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
    Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
    Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gingival rhabdomyosarcoma mimicking a non-neoplastic proliferative lesion: A diagnostic challenge.
    Cavalcante IL; Cunha JLS; da Silva CCB; Nonaka CFW; Cavalcante ER; de Almeida OP; Ribeiro NRB; Turatti E; Cavalcante RB; de Andrade BAB
    Oral Oncol; 2023 Feb; 137():106281. PubMed ID: 36549241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma.
    Tuohy JL; Byer BJ; Royer S; Keller C; Nagai-Singer MA; Regan DP; Seguin B
    Vet Pathol; 2021 May; 58(3):516-526. PubMed ID: 33691532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rhabdomyosarcoma of the head and neck in pediatric patients: a systematic review.
    Rodríguez-Vargas MP; Villanueva-Sánchez FG
    Med Oral Patol Oral Cir Bucal; 2022 Nov; 27(6):e569-e577. PubMed ID: 36173721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
    Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
    Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.